Primary outcome was average pain intensity measured at day @ ( NRS , @ to @ ) ; secondary outcomes were analgesic consumption ( oral morphine equivalents ) , fatigue and appetite loss ( European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire C@ , @ to @ ) , and patient satisfaction ( NRS , @ to @ ) .